Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$993K Buy
+2,500
New +$712K ﹤0.01% 3619
2026
Q1
Sell
-1,000
Closed -$256K 4732
2025
Q4
$256K Buy
+1,000
New +$262K ﹤0.01% 3657
2022
Q1
Sell
-14,500
Closed -$6.73M 3403
2021
Q4
$6.73M Sell
14,500
-15,200
-51% -$6.73M 0.01% 1024
2021
Q3
$11.6M Buy
29,700
+20,600
+226% +$8.74M 0.03% 707
2021
Q2
$4.03M Buy
+9,100
New +$3.98M 0.01% 1332
2021
Q1
Sell
-4,800
Closed -$1.97M 4007
2020
Q4
$1.97M Buy
+4,800
New +$2M 0.01% 1497
2020
Q3
Sell
-2,100
Closed -$814K 3292
2020
Q2
$814K Buy
2,100
+200
+11% +$74.8K ﹤0.01% 1664
2020
Q1
$597K Sell
1,900
-11,500
-86% -$3.88M ﹤0.01% 1800
2019
Q4
$4.91M Buy
13,400
+3,600
+37% +$1.14M 0.01% 962
2019
Q3
$2.51M Sell
9,800
-17,100
-64% -$4.79M 0.01% 1254
2019
Q2
$7.14M Buy
26,900
+25,800
+2,345% +$6.54M 0.02% 744
2019
Q1
$293K Sell
1,100
-1,900
-63% -$548K ﹤0.01% 2614
2018
Q4
$859K Sell
3,000
-1,000
-25% -$317K ﹤0.01% 1750
2018
Q3
$1.35M Sell
4,000
-9,000
-69% -$2.92M ﹤0.01% 1764
2018
Q2
$3.87M Sell
13,000
-1,600
-11% -$469K 0.01% 1163
2018
Q1
$3.92M Sell
14,600
-5,700
-28% -$1.54M 0.01% 1092
2017
Q4
$5.04M Buy
+20,300
New +$5.01M 0.02% 895
2017
Q3
Sell
-1,000
Closed -$241K 2944
2017
Q2
$241K Buy
+1,000
New +$226K ﹤0.01% 2732

Other funds holding HUM

John Overdeck's HUM Position: Q2 2026 in Review

John Overdeck sold out of Humana (HUM) in Q2 2026, closing a stake of 58,700 shares — an estimated $16.7M sold.

John Overdeck first reported a position in HUM in Q2 2013 and held it in 42 quarters. The position peaked at $239M in Q1 2024. 919 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • John Overdeck reported no remaining Humana position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 58,700 Humana shares in Q2 2026, an estimated $16.7M.
  • John Overdeck first reported a position in Humana in Q2 2013 and held it in 42 quarters.
  • John Overdeck's Humana position peaked at $239M in Q1 2024.
  • 919 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.